Insider Sell: Cytek Biosciences Inc's CTO Ming Yan Disposes of 20,000 Shares
Ming Yan, Chief Technology Officer of Cytek Biosciences Inc (NASDAQ:CTKB), sold 20,000 shares of the company on December 19, 2023, according to a recent SEC Filing.
Stay updated with breaking news from Bing Yan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ming Yan, Chief Technology Officer of Cytek Biosciences Inc (NASDAQ:CTKB), sold 20,000 shares of the company on December 19, 2023, according to a recent SEC Filing.
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
The Center for Drug Evaluation of China’s National Medical Products Administration has accepted the new drug application seeking the approval of the next-generation ROS1 TKI taletrectinib for the treatment of patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer with prior exposure to a ROS1 TKI.
NEW YORK & SUZHOU, China--(BUSINESS WIRE)--Nov 22, 2023--
NEW YORK & SUZHOU, China--(BUSINESS WIRE)--Nov 22, 2023--